RESEARCH-USE BIOSIMILAR ANTIBODY
Cantuzumab
Antibody-drug conjugate · IgG1
Cantuzumab is a monoclonal antibody that can binds the CanAg antigen. Cantuzumab is typically linked to one of several cytotoxic agents, yielding antibody-drug conjugates (ADC), such as Cantuzumab mertansine (HY-P99492) and Cantuzumab ravtansine (HY-P99493).
TARGETMUC1
YAntibody-drug conjugate
CATALOGSC-BS-689
CATALOG NUMBERSC-BS-689
MOLECULAR WEIGHTApprox. 147.02 kDa
PRODUCT FORMATAntibody-drug conjugate
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Cantuzumab is a monoclonal antibody that can binds the CanAg antigen. Cantuzumab is typically linked to one of several cytotoxic agents, yielding antibody-drug conjugates (ADC), such as Cantuzumab mertansine (HY-P99492) and Cantuzumab ravtansine (HY-P99493).
Cantuzumab is a recombinant research-use antibody directed against MUC1.